treatment of ho-di rats with arginine-vasopressin , des-glycinamide arginine vasopressin , or 1-desamino-8-d-arginine-vasopressin daily for 1 week resulted in an elevation of receptor capacity in hippocampus and anterior pituitary near the level observed in nondiabetic controls .
C0003779
arginine vasopressin
C0011701
daily